Screening for Symptoms of COVID-19 & Infectious Diseases for UK Clients
Utilizing our COVID-19 & Infectious Diseases technology, Taurus Medical Solutions are offering entry modules to the healthcare, retail, and the entertainment sector in the UK.
For UK Clients
Simply fill out the form below and we’ll be in touch.
Powered by Artificial Intelligence.

Quick, non-invasive, contactless screening
Fully automated without the need for personnel to operate
Indicates positive or negative result so safety protocols can be initiated
Infections including COVID-19, produce unique physiological patterns that our AI powered technology will detect, assess, and determine the probability of that person being infected or not infected.
As the virus mutates, our AI will learn how new symptoms present new patterns from which to continue detecting infection.

In the News
PredictMedix Is Partnering With McGill Researchers for Clinical Research
TORONTO, ON / ACCESSWIRE / November 10, 2020 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce that the company is partnering with the research group led by Dr. Samira Rahimi for clinical research. Professor Rahimi is...
PredictMedix Provides Corporate Update
TORONTO, ON / ACCESSWIRE / October 27, 2020 / PredictMedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to provide a corporate update on its recent activities in relation to its infectious disease screening technology and its remote...
Accenture: Health innovation: A cure for COVID-19 disruptions
Bets on a better future A select group of health systems and hospitals are differentiating themselves from their peers, investing in the innovations they need to navigate the long-term uncertainties imposed by COVID-19. These organizations have pinpointed innovation...
How does the tech respond to people who are completely asymptomatic?
Data from published epidemiology and virologic studies provide evidence that COVID-19 is primarily transmitted from symptomatic people to others who are in close contact through respiratory droplets, by direct contact with infected persons, or by contact with contaminated objects and surfaces. This is supported by detailed experiences shared by technical partners via WHO global expert networks, and reports and presentations by Ministries of Health. As such based on current data, symptomatic transmission is responsible for the spread of COVID-19. Therefore, the key is to identify the majority of symptomatic individuals to prevent transmission which is the purpose of our mass screening technology.
Will I show “positive” with a common cold or flu?
How long does the system take to process a scan?
Does the system require installation of any other hardware?
How does the PredictMedix software differ than other fever scanners on the market?
What kind of internet bandwidth is required for the mass screening?
Typically internet bandwidth of above 25 Mbps is required for a single scan station.